Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-02 Sale | 2024-12-02 6:00 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $21.73 | $125,155 | 87,830 (Direct) | View |
| 2024-11-04 Sale | 2024-11-04 5:48 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,290 | $25 | $82,250 | 124,473 (Direct) | View |
| 2024-11-01 Sale | 2024-11-01 5:57 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $24.28 | $139,867 | 93,590 (Direct) | View |
| 2024-11-01 Sale | 2024-11-01 5:57 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 3,546 | $24.28 | $86,083 | 33,724 (Direct) | View |
| 2024-10-30 Sale | 2024-10-30 8:30 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 2,368 | $24.3 | $57,554 | 101,201 (Direct) | View |
| 2024-10-30 Sale | 2024-10-30 8:30 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 3,437 | $24.3 | $83,536 | 116,204 (Direct) | View |
| 2024-10-30 Sale | 2024-10-30 8:30 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 4,182 | $24.3 | $101,644 | 87,205 (Direct) | View |
| 2024-10-14 Sale | 2024-10-15 09:16 am | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,290 | $25 | $82,250 | 124,271 (Direct) | View |
| 2024-10-01 Sale | 2024-10-01 7:36 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $22.23 | $128,017 | 95,858 (Direct) | View |
| 2024-09-03 Sale | 2024-09-03 5:33 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 9,050 | $24.94 | $225,736 | 204,587 (Direct) | View |
| 2024-08-26 Sale | 2024-08-26 6:23 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 9,870 | $25.01 | $246,843 | 136,388 (Direct) | View |
| 2024-08-26 Sale | 2024-08-26 5:41 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 20,000 | $25.22 | $504,370 | 31,002 (Direct) | View |
| 2024-08-01 Sale | 2024-08-01 7:06 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 3,477 | $21.45 | $74,576 | 51,002 (Direct) | View |
| 2024-08-01 Sale | 2024-08-01 7:06 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $21.43 | $123,459 | 107,378 (Direct) | View |
| 2024-07-30 Sale | 2024-07-30 7:06 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 3,408 | $20.67 | $70,436 | 119,641 (Direct) | View |
| 2024-07-30 Sale | 2024-07-30 7:06 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 2,920 | $20.67 | $60,350 | 91,387 (Direct) | View |
| 2024-07-30 Sale | 2024-07-30 7:06 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 2,490 | $20.67 | $51,463 | 127,046 (Direct) | View |
| 2024-07-01 Sale | 2024-07-01 6:35 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $20.81 | $119,837 | 108,384 (Direct) | View |
| 2024-06-20 Sale | 2024-06-20 4:58 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 20,000 | $20.01 | $400,216 | 48,333 (Direct) | View |
| 2024-06-13 Sale | 2024-06-13 6:39 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 1,864 | $17.02 | $31,721 | 114,144 (Direct) | View |
| 2024-06-12 Sale | 2024-06-12 7:30 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 1,900 | $17.01 | $32,319 | 116,008 (Direct) | View |
| 2024-06-05 Sale | 2024-06-05 6:01 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 400 | $17 | $6,801 | 117,908 (Direct) | View |
| 2024-06-03 Sale | 2024-06-03 6:36 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 1,596 | $17.01 | $27,153 | 118,308 (Direct) | View |
| 2024-05-02 Sale | 2024-05-02 6:01 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 3,499 | $12.83 | $44,878 | 68,333 (Direct) | View |
| 2024-04-30 Sale | 2024-04-30 6:33 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 1,387 | $12.04 | $16,703 | 108,035 (Direct) | View |
| 2024-04-30 Sale | 2024-04-30 6:33 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 2,007 | $12.04 | $24,169 | 78,049 (Direct) | View |
| 2024-04-30 Sale | 2024-04-30 6:33 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 1,513 | $12.04 | $18,220 | 49,307 (Direct) | View |
| 2024-02-16 Sale | 2024-02-16 7:20 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 6,812 | $10.02 | $68,223 | 68,333 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-02 Exercise | 2024-12-02 6:00 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $1.86 | 87,830 (Direct) | View |
| 2024-12-02 Exercise | 2024-12-02 6:00 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $0 | 87,830 (Direct) | View |
| 2024-11-04 Exercise | 2024-11-04 5:48 pm | N/A 2030-05-27 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,290 | $0 | 124,473 (Direct) | View |
| 2024-11-04 Exercise | 2024-11-04 5:48 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,290 | $9.57 | 124,473 (Direct) | View |
| 2024-11-01 Exercise | 2024-11-01 5:57 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $1.86 | 93,590 (Direct) | View |
| 2024-11-01 Exercise | 2024-11-01 5:57 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $0 | 93,590 (Direct) | View |
| 2024-10-30 Exercise | 2024-10-30 8:30 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 8,636 | $0 | 101,201 (Direct) | View |
| 2024-10-30 Exercise | 2024-10-30 8:30 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 8,957 | $0 | 116,204 (Direct) | View |
| 2024-10-30 Exercise | 2024-10-30 8:30 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 7,674 | $0 | 87,205 (Direct) | View |
| 2024-10-15 Option Award | 2024-10-16 4:48 pm | N/A 2034-10-14 | Nurix Therapeutics Inc. | NRIX | Kapur Anil Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2024-10-14 Exercise | 2024-10-15 09:16 am | N/A 2030-05-27 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,290 | $0 | 124,271 (Direct) | View |
| 2024-10-14 Exercise | 2024-10-15 09:16 am | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,290 | $9.57 | 124,271 (Direct) | View |
| 2024-10-01 Exercise | 2024-10-01 7:36 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $1.86 | 95,858 (Direct) | View |
| 2024-10-01 Exercise | 2024-10-01 7:36 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $0 | 95,858 (Direct) | View |
| 2024-09-03 Exercise | 2024-09-03 5:33 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $1.86 | 204,587 (Direct) | View |
| 2024-09-03 Exercise | 2024-09-03 5:33 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 9,050 | $0 | 204,587 (Direct) | View |
| 2024-09-03 Exercise | 2024-09-03 5:33 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,290 | $9.57 | 204,587 (Direct) | View |
| 2024-08-26 Exercise | 2024-08-26 6:23 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 4,463 | $1.86 | 136,388 (Direct) | View |
| 2024-08-26 Exercise | 2024-08-26 6:23 pm | N/A 2029-11-13 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 9,870 | $0 | 136,388 (Direct) | View |
| 2024-08-26 Exercise | 2024-08-26 6:23 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,407 | $9.57 | 136,388 (Direct) | View |
| 2024-08-01 Exercise | 2024-08-01 7:06 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $1.86 | 107,378 (Direct) | View |
| 2024-08-01 Exercise | 2024-08-01 7:06 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $0 | 107,378 (Direct) | View |
| 2024-07-30 Exercise | 2024-07-30 7:06 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 8,957 | $0 | 119,641 (Direct) | View |
| 2024-07-30 Exercise | 2024-07-30 7:06 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 7,674 | $0 | 91,387 (Direct) | View |
| 2024-07-30 Exercise | 2024-07-30 7:06 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 8,636 | $0 | 127,046 (Direct) | View |
| 2024-07-17 Gift | 2024-07-18 4:06 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Kunkel Lori Anne Director | 54,027 | $0 | 0 (Direct) | View |
| 2024-07-01 Exercise | 2024-07-01 6:35 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $1.86 | 108,384 (Direct) | View |
| 2024-07-01 Exercise | 2024-07-01 6:35 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,760 | $0 | 108,384 (Direct) | View |
| 2024-06-13 Exercise | 2024-06-13 6:39 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 1,864 | $1.86 | 114,144 (Direct) | View |
| 2024-06-13 Exercise | 2024-06-13 6:39 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 1,864 | $0 | 114,144 (Direct) | View |
| 2024-06-12 Exercise | 2024-06-12 7:30 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 1,900 | $1.86 | 116,008 (Direct) | View |
| 2024-06-12 Exercise | 2024-06-12 7:30 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 1,900 | $0 | 116,008 (Direct) | View |
| 2024-06-05 Exercise | 2024-06-05 6:01 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 400 | $1.86 | 117,908 (Direct) | View |
| 2024-06-05 Exercise | 2024-06-05 6:01 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 400 | $0 | 117,908 (Direct) | View |
| 2024-06-03 Exercise | 2024-06-03 6:36 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 1,596 | $1.86 | 118,308 (Direct) | View |
| 2024-06-03 Exercise | 2024-06-03 6:36 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 1,596 | $0 | 118,308 (Direct) | View |
| 2024-05-20 Option Award | 2024-05-20 7:26 pm | N/A 2034-05-19 | Nurix Therapeutics Inc. | NRIX | Silva Paul M Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-05-20 Option Award | 2024-05-20 7:26 pm | N/A 2034-05-19 | Nurix Therapeutics Inc. | NRIX | Kunkel Lori Anne Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-05-20 Option Award | 2024-05-20 7:25 pm | N/A 2034-05-19 | Nurix Therapeutics Inc. | NRIX | GREGORY JULIA P Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-05-20 Option Award | 2024-05-20 7:25 pm | N/A 2034-05-19 | Nurix Therapeutics Inc. | NRIX | Lacey David L. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-05-20 Option Award | 2024-05-20 7:25 pm | N/A 2034-05-19 | Nurix Therapeutics Inc. | NRIX | Reinsdorf Judith A Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-05-20 Option Award | 2024-05-20 7:25 pm | N/A 2034-05-19 | Nurix Therapeutics Inc. | NRIX | Saltzman Edward C Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-04-30 Exercise | 2024-04-30 6:33 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 4,886 | $0 | 108,035 (Direct) | View |
| 2024-04-30 Exercise | 2024-04-30 6:33 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 5,206 | $0 | 78,049 (Direct) | View |
| 2024-04-30 Exercise | 2024-04-30 6:33 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,924 | $0 | 49,307 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 07:23 am | N/A 2034-02-12 | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 195,000 | $0 | 195,000 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 07:23 am | N/A 2034-02-12 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 195,000 | $0 | 195,000 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 07:23 am | N/A 2034-02-12 | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 195,000 | $0 | 195,000 (Direct) | View |